The effect of Mg on the cardiac biomarker proBNP
- Conditions
- Atherosclerotic heart disease.Atherosclerotic heart disease
- Registration Number
- IRCT201205069650N1
- Lead Sponsor
- Anesthesiology Research Center, Shahid Beheshtil Universityof medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
significant coronary artery stenosis (2VD or 3VD) and EF<45%. Exclusion criteria: 1.Conduction abnormality (branch block); 2.AF rhythm; 3.Diabetes mellitus. 4.cr>1.8; 5.Emergent surgery; 6.Unstable angina; 7.Redo surgery; 8.Combination surgery (carotid endarterectomy, vulvoplasty); 9.long QT syndrome, neuromuscular junction disorders.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ProBNP. Timepoint: before intervention, 24 hours after intervention. Method of measurement: ELISA based lab kit.
- Secondary Outcome Measures
Name Time Method Mechanical ventilation time. Timepoint: days on mechanical ventilation. Method of measurement: questionnaire.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.